Salazar A, Chercoles AG, Palom A, Ruiz A, Garcia-Fernandez AE, Blanco-Grau A, Mantovani A, Zanella A, Holten AR, Mayer A, Bandera A, Cherubini A, Protti A, Aghemo A, Gerussi A, Ramirez A, Braun A, Nebel [...] Nebel A, Barreira A, Lleo A, Teles A, Kildal AB, Biondi A, Caballero-Garralda A, Ganna A, Gori A, Gluck A, Lind A, Tanck A, Hinney A, Nolla AC, Fracanzani AL, Peschuck A, Cavallero A, Dyrhol-Riise AM, Ruello [...] Sharma AR, Elkady A, Negro A, Günther A, Gutschalk A, Schönenberger S, Buture A, Murphy S, Paiva Nunes A, Tiede A, Puthuppallil Philip A, Mengel A, Medina A, Hellstrom Vogel A, Tawa A, Aujayeb A, Casolla B,

Failure, 8:3070-3081, 2021. Bagshaw S, Al-Khafaji A, Artigas A, Davison D, Haase M , Lissauer M, Zacharowski K, Chawla L, Kwan T, Kampf P, McPherson P, Kellum J#. External Validation of Urinary C-C motif [...] 5741, 2021. Elitok S, Devarajan P, Bellomo R, Isermann B, Haase M # , Haase-Fielitz A. NGAL/hepcidin-25 ratio and AKI subtypes in patients following cardiac surgery: A prospective observational study. [...] Care , 25:185, 2021 Albert C#, Zapf A, Haase M , Röver C, Pickering JW, Albert A, Bellomo R, Breidthardt T, Camou F, Chen Z, Chocron S, Cruz D, de Geus HRH, Devarajan P, Di Somma S, Doi K, Endre ZH, Gar

literature on bioethical topics: Results from a meta-review. Nurs Ethics. 2020 doi: 10.1177/0969733020907935 Nobile, H , Borry, P, Pischon, T, Steinbrecher, A, Boeing, H, Vigl, M, Bergmann MM. Participants’ [...] 9 Nobile, H , Bergmann, MM, Moldenhauer, J, & Borry, P. Participants' Accounts on Their Decision to Join a Cohort Study With an Attached Biobank: A Qualitative Content Analysis Study Within Two German [...] Ollenberger, A, Borry, P, Nobile, H , Bergmann, M, & Caulfield, T. Newspaper coverage of biobanks. PeerJ, 2014, 2, e500. doi: 10.7717/peerj.500 Nobile H , Vermeulen E, Thys K, Bergmann M, Borry P. Why do

; Popov, P. A.; Soloviov, D., V; Alekseev, A. A.; Kovalev, K., V; Zabelskii, D., V; Chizhov, I., V; Borshchevskiy, V., I; Rokitskaya, T., I; Antonenko, Y. N.; Dolgikh, D. A.; Kirpichnikov, M. P.; Gordeliy [...] Kononenko A.A., Chamorovsky S.K., Chernavskaja N.M. (1989) Physical aspects of bacteriorhodopsin functioning. Izvestija.Acad.Sci.(USSR) 5:701-709. Zubov B.V., Kononenko A.A., Murina T.M., Nocks P.P., Rubin [...] Journal 76 (1): A242-A242 Part 2. Chizhov I., Weiss S., Geeves M. (1999) Transient kinetics of actomyosin using 100 ng of proteins. Biophysical Journal 76 (1): A38-A38 Part 2. Geeves M.A., Chizhov I. (1998)

Kühner P, Rohde H, Peschel A. Genetic engineering of untransformable coagulase-negative staphylococcal pathogens. Nat Protoc. 2016;11(5):949-59. Li X, Gerlach D, Du X, Larsen J, Stegger M, Kühner P, Peschel [...] e00632-15. Winstel V*, Kühner P, Krismer B, Peschel A, Rohde H. Transfer of plasmid DNA to clinical coagulase-negative staphylococcal pathogens by using a unique bacteriophage. Appl Environ Microbiol. 2015; 81 [...] Sanchez-Carballo P, Holst O, Xia G, Peschel A. Biosynthesis of the unique wall teichoic acid of Staphylococcus aureus lineage ST395. mBio. 2014;5(2):e00869. Winstel V, Liang C, Sanchez-Carballo P, Steglich M

Monday, 2025-24-11, 9:00 a.m. – 4:30 p.m. at CRC: Basic course for clinical trials according to EU regulation no. 536/2014 (human medicine) Tuesday, 2025-25-11 , 9:00 a.m. – 4:30 p.m. at CRC: Basic course [...] Wednesday, 2025-26-11, 9:00 a.m. – 4:30 p.m. at CRC: Advanced course for clinical trials according to EU regulation no. 536/2014 (human medicine ) Thursday, 2025-27-11, 9:00 a.m. – 1:30 p.m. at CRC: Refresher [...] welcome at the events as internal MHH participants. We are currently conducting a survey to identify whether there is a demand for “online live GCP courses”. If you are interested, please fill out the

Ssebyatika GL, Jürgens C, Plückebaum N, Beck M, Hassan A, Tan L, Demera A, Janssen A, Steinberger P, Koenecke C, Viejo-Borbolla A, Messerle M, Krey T, Prinz I. A CMV-induced adaptive human Vδ1+ γδ T cell clone [...] Tomaszewska A, Jagasia M, Beohou E, van der Werf S, Blaise D, Kanfer E, Milpied N, Reményi P, Ciceri F, Bourhis JH, Chevallier P, Solano C, Socié G, Bruno B, Rambaldi A, Castagna L, Kröger N, Corradini P, Afanasyev [...] Saborowski A, Schütt J, Limbourg F, Könecke C, Schreder A, Michael A, Misslitz AC, Healy ME, Geffers R, Clavel T, Haller D, Unger K, Finegold M, Weber A, Manns MP, Longerich T, Heikenwälder M, Vogel A. Dual

Gongadze G, Kalinin A, Meshcheryakov V, Moskalenko S, Mudrik E, Nevskaya N, Nikonov S, Nikulin A, Peredelina A, Rak A, Serganov A, Shcherbakov D, Tin O, Tishchenko S, Vassilieva J, Kraft A, Piendl W, Ehresmann [...] ; 2 (6), 1565 – 1574. Matter HH, Arun Kumar HS, Fedorov R, Frey A, Kotsonis P, Hartmann E, Fröhlich LG, Reif A, Pfleiderer W, Scheurer P, Ghosh DK, Schlichting I and Schmidt HHHW. Structural Analysis of [...] and reaction mechanism. (2017) Sci. Rep. 7 (1):4160. Lohöfener J, Steinke N, Kay-Fedorov P, Baruch P, Nikulin A, Tishchenko S, Manstein DJ, and Fedorov R. The activation mechanism of 2’-5’-oligoadenylate

Rai, A., Klare, J.P., Reinke, P.Y.A, Englmaier, F., Fohrer, J., Fedorov, R., Taft, M.H. Chizhov, I., Curth,U., Plettenburg, O., Manstein, D.J. (2021) Structural and biochemical characterization of a dye [...] Katzka, C. ,Rai, A. ,Wolf, A. Brockmeyer, A. Janning, P. Reubold, T.F., Eschenburg, S., Manstein, D.J., Hubel, K. Kaiser, M. and Waldmann, H. (2009) The Ras Pathway Modulator Melophlin A Targets Dynamins [...] cardiac α -actin mutations A21V and D26N implicated in hypertrophic cardiomyopathy . Cytoskeleton, 1–17. doi: 10.1002/cm.21852 Kengyel, A., Palarz, P. M., Krohn, J., Marquardt, A., Greve, J. N., Heiringhoff

diseases underlying depression in a first step. In a second step, specific biomarkers will be used to determine these diseases in each individual patient and then to treat them in a targeted manner. Professor [...] not help them," explains Professor Frieling. A sub-project of the research network is therefore investigating in a clinical trial how the BDNF marker as a blood test can improve the care of depressed people [...] Biomarkers help in depression therapy P4D takes advantage of the fact that depressives respond very differently to different forms of therapy. This is because, on a neurobiological level, the clinical picture